17-8161759-TCCA-T
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PM4_SupportingPP5_Moderate
The NM_014232.3(VAMP2):c.128_130del(p.Val43del) variant causes a inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Consequence
VAMP2
NM_014232.3 inframe_deletion
NM_014232.3 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.32
Genes affected
VAMP2 (HGNC:12643): (vesicle associated membrane protein 2) The protein encoded by this gene is a member of the vesicle-associated membrane protein (VAMP)/synaptobrevin family. Synaptobrevins/VAMPs, syntaxins, and the 25-kD synaptosomal-associated protein SNAP25 are the main components of a protein complex involved in the docking and/or fusion of synaptic vesicles with the presynaptic membrane. This gene is thought to participate in neurotransmitter release at a step between docking and fusion. The protein forms a stable complex with syntaxin, synaptosomal-associated protein, 25 kD, and synaptotagmin. It also forms a distinct complex with synaptophysin. It is a likely candidate gene for familial infantile myasthenia (FIMG) because of its map location and because it encodes a synaptic vesicle protein of the type that has been implicated in the pathogenesis of FIMG. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
PM1
In a domain v-SNARE coiled-coil homology (size 60) in uniprot entity VAMP2_HUMAN there are 10 pathogenic changes around while only 0 benign (100%) in NM_014232.3
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_014232.3. Strenght limited to Supporting due to length of the change: 1aa.
PP5
Variant 17-8161759-TCCA-T is Pathogenic according to our data. Variant chr17-8161759-TCCA-T is described in ClinVar as [Pathogenic]. Clinvar id is 666257.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr17-8161759-TCCA-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VAMP2 | NM_014232.3 | c.128_130del | p.Val43del | inframe_deletion | 3/5 | ENST00000316509.11 | |
VAMP2 | NM_001330125.1 | c.134_136del | p.Val45del | inframe_deletion | 3/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VAMP2 | ENST00000316509.11 | c.128_130del | p.Val43del | inframe_deletion | 3/5 | 1 | NM_014232.3 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 31, 2020 | - - |
Severe neurodevelopmental delay Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Genetics Laboratory - UDIAT Centre Diagnòstic, Hospital Universitari Parc Tauli | Jul 10, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at